نتایج جستجو برای: cd4 counts

تعداد نتایج: 110797  

2014
Jaiprasath Sachithanandham Veena Vadhini Ramalingam Jaganathan Raja Ooriyapadickal Cherian Abraham Susanne A Pulimood Rajesh Kannangai

Results The mRNA expressions of all the 4 cytokines in HIV-1 infected individuals were significantly higher compared to healthy controls (p value range 0.0004-0.01). The mean level of IL-10, INF-gamma and TNF alpha were higher in HIV infected individuals with low CD4 counts (<300 cells/μL). The IL-10 expression showed a significant negative correlation with CD4 counts (r = -0.25, p = 0.04) whil...

2016
Tommy Saing Anddre Valdivia Parveen Hussain Judy Ly Leslie Gonzalez Frederick T Guilford Daniel Pearce Vishwanath Venketaraman

Our most recent data indicate differences in the levels of pro-inflammatory cytokines (IL-1β, IL-17, and IL-6) and malondialdehyde (MDA), a stable end-product of lipid peroxidation in the plasma samples between HIV positive individuals with low CD4 T cell counts <200 mm(3) and HIV positive individuals with CD4 T cell counts between 200 and 300 mm(3) (ee). The data lend support and provide valua...

Journal: :AIDS 2010
Nathan Ford Katharina Kranzer Katherine Hilderbrand Guillaume Jouquet Eric Goemaere Nathalie Vlahakis Laura Triviño Lipontso Makakole Helen Bygrave

INTRODUCTION The latest WHO guidelines recommend initiating antiretroviral therapy (ART) at CD4 cell counts less than 350 cells/μl. However, donors and national governments are reluctant to support implementation owing to uncertainty regarding feasibility and relative benefit. Lesotho has supported earlier initiation since 2008. We assessed outcomes comparing early (CD4 cell counts >200 cells/μ...

Journal: :Blood 2002
JoAnn C Castelli Steven G Deeks Stephen Shiboski Jay A Levy

During chronic HIV infection, asymptomatic individuals demonstrate a strong CD8(+) cell noncytotoxic antiviral response (CNAR). With the onset of symptoms or reduction in CD4(+) cell counts, CNAR decreases. Presently, it is recommended that infected individuals receive antiretroviral therapy if CD4(+) cell counts fall below 350 cells/microL. To determine whether CNAR lends support to this recom...

2010
Emmanuel Oni Idigbe Rosemary A. Audu Edna O. Iroha Adebola O. Akinsulie Edamisan Olusoji Temiye Veronica C. Ezeaka Ifedayo M. O. Adetifa Adesola Z. Musa Joseph Onyewuche Sylvester U. Ikondu

Population studies showed that there are differences in T-lymphocytes subpopulation of normal children in different regions, and reference values in an area might be different from another. This study compared the values in our population with CDC and WHO reference values. Blood samples from 279 healthy, HIV-negative children <12 years of age were analysed for complete blood count, CD3+, CD4+, ...

Journal: :The Journal of infectious diseases 2004
Colette J Smith Caroline A Sabin Mike S Youle Sabine Kinloch-de Loes Fiona C Lampe Sara Madge Ian Cropley Margaret A Johnson Andrew N Phillips

BACKGROUND Highly active antiretroviral therapy (HAART) results in an improvement in immunologic function. We sought to investigate the factors associated with increases in CD4 cell count among human immunodeficiency virus (HIV)-positive antiretroviral-naive patients starting HAART. METHODS Five hundred ninety-six subjects were followed for a median of 2.5 years (interquartile range, 1.0-4.0 ...

Journal: :The Journal of allergy and clinical immunology 2000
W T Shearer K A Easley J Goldfarb H M Rosenblatt H B Jenson A Kovacs K McIntosh

BACKGROUND Peripheral blood CD4(+) and CD8(+) T cells, CD19(+)/20(+) B cells, and serum Igs are known to be altered by the progression of pediatric HIV-1 infection, but their evaluation as predictors of survival needs further definition. OBJECTIVE To determine the natural history of these immune factors and their importance in predicting survival, we studied 298 HIV-1 vertically infected (HIV...

Journal: :Clinical and vaccine immunology : CVI 2007
Justen Manasa Hazvineyi Musabaike Collen Masimirembwa Eileen Burke Ruedi Luthy James Mudzori

A single-platform volumetric flow cytometer, the Partec Cyflow SL_3, was evaluated against a BD FACSCalibur/Sysmex XT1800i dual platform for measuring CD4(+) lymphocytes, total lymphocytes, and the percentage of CD4 lymphocytes in whole-blood samples for monitoring the immune systems of human immunodeficiency virus (HIV)/AIDS patients. Statistical analyses for precision, correlation, and agreem...

2011
Reena Rajasuriar Maelenn Gouillou Tim Spelman Tim Read Jennifer Hoy Matthew Law Paul U. Cameron Kathy Petoumenos Sharon R. Lewin

BACKGROUND A small but significant number of patients do not achieve CD4 T-cell counts >500 cells/µl despite years of suppressive cART. These patients remain at risk of AIDS and non-AIDS defining illnesses. The aim of this study was to identify clinical factors associated with CD4 T-cell recovery following long-term cART. METHODS Patients with the following inclusion criteria were selected fr...

2013
Marie-Quitterie Picat Joanna Lewis Victor Musiime Andrew Prendergast Kusum Nathoo Addy Kekitiinwa Patricia Nahirya Ntege Diana M. Gibb Rodolphe Thiebaut A. Sarah Walker Nigel Klein Robin Callard

BACKGROUND Long-term immune reconstitution on antiretroviral therapy (ART) has important implications for HIV-infected children, who increasingly survive into adulthood. Children's response to ART differs from adults', and better descriptive and predictive models of reconstitution are needed to guide policy and direct research. We present statistical models characterising, qualitatively and qua...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید